Press Release

Printer Friendly Version View printer-friendly version
<< Back
Global Blood Therapeutics Announces Participation at the Stifel 2017 Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT) today announced that it will present at the Stifel 2017 Healthcare Conference in New York City on Tuesday, November 14, 2017 at 2:00 p.m. Eastern Time.

The presentation will be webcast live and available for replay from GBT’s website at in the Investors section.

About Global Blood Therapeutics
Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need. GBT is developing its late-stage product candidate, voxelotor, as an oral, once-daily therapy for sickle cell disease. To learn more, please visit: and follow the company on Twitter: @GBT_news

Contact Information:
Myesha Lacy (investors)

Julie Normart (media)
Pure Communications

Global Blood Therapeutics, Inc.